| Financial Year |
March 31 2023 |
| Monetary Funds |
391,813,483.06 |
| Held-for-trading Financial Assets |
287,004,928.07 |
| Notes Receivable |
-- |
| Accounts Receivable |
22,994,735.57 |
| Advances to Suppliers |
15,213,343.13 |
| Other Receivables |
18,154,570.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,010,219.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,000,000.00 |
| Other Current Assets |
1,317,110.31 |
| Total Current Assets |
879,508,390.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
51,984,496.88 |
| Under-construction Projects |
12,284,263.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,503,546.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,883,802.73 |
| Deferred Income Tax Assets |
11,482,306.23 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
156,068,423.36 |
| Total Assets |
1,035,576,813.72 |
| Short-Term Loans |
118,667,758.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,992,671.01 |
| Accounts Payable |
41,529,629.52 |
| Accounts Received In Advance |
51,163.27 |
| Employee Compensation Payable |
9,502,191.30 |
| Taxes Payable |
5,775,683.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,730,997.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,748,537.51 |
| Other Current Liabilities |
1,154,161.58 |
| Sub-Total of Current Liabilities |
261,149,546.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,310,981.75 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,651,613.21 |
| Total Liabilities |
299,801,159.95 |
| Paid-In Capital(Or Share Stock) |
326,341,682.00 |
| Capital Surplus |
159,684,308.90 |
| Surplus Reserve |
42,297,411.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
207,452,251.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
735,775,653.77 |
| Owner's Equity（Stockholder's Equity） |
735,775,653.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,035,576,813.72 |
